Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -5668.62% is 2704% below its 5-year average of -202.19%, near the low end of its 5-year range (-5668.62%–13.83%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-5668.62%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-256.43%
NET PROFIT MARGIN AVG 5Y
-202.19%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-2110.55%
CURRENT VS 5Y AVG
-2703.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-2180138.46%
vs the sector median at left
ImageneBio Inc
Market Cap
$53.01M
Net Profit Margin
-5668.62%
TTM Avg
0.00%
3Y Avg
-256.43%
5Y Avg
-202.19%
Market Cap
$53.62M
Net Profit Margin
-69.27%
TTM Avg
-45.15%
3Y Avg
-54.32%
5Y Avg
-40.58%
Market Cap
$53.55M
Net Profit Margin
-59.97%
TTM Avg
-26.95%
3Y Avg
-5.27%
5Y Avg
-0.58%
Market Cap
$53.63M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.90M
Net Profit Margin
-618.02%
TTM Avg
-2368.57%
3Y Avg
-1184.28%
5Y Avg
-1443.19%
Market Cap
$51.46M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImageneBio Inc (IMA) | $53.01M | -5668.62% | 0.00% | -256.43% | -202.19% |
| Aldeyra The (ALDX)vs › | $53.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | -69.27% | -45.15% | -54.32% | -40.58% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $53.55M | -59.97% | -26.95% | -5.27% | -0.58% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.90M | -618.02% | -2368.57% | -1184.28% | -1443.19% |
| biote Corp. (BTMD)vs › | $52.05M | 3.19% | 7.83% | 4.22% | 10.88% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Clene Inc. (CLNN)vs › | $50.51M | -20059.90% | -12303.49% | -9625.39% | -8201.08% |
Operating Margin
-6056.4%
Net Profit Margin
-5668.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -759.63% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -2957.36% |
| 2023-09-30 | -1463.54% |
| 2023-06-30 | -854.04% |
| 2023-03-31 | -267.63% |
| 2022-12-31 | -258.66% |
| 2022-09-30 | -270.82% |
| 2022-06-30 | -5364.14% |
| 2022-03-31 | -497.61% |
| 2021-12-31 | 13.83% |
| 2021-09-30 | -387.48% |
| 2021-06-30 | -357.31% |
| 2021-03-31 | -279.68% |
| 2020-12-31 | -40078.46% |
| 2020-09-30 | -219.94% |
| 2020-06-30 | -163.94% |
| 2020-03-31 | -215.22% |
| 2019-12-31 | -182.17% |
